T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.96B |
| 3 |
Global Payments
GPN
|
+$1.95B |
| 4 |
Salesforce
CRM
|
+$1.48B |
| 5 |
Boeing
BA
|
+$1.47B |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.45B |
| 5 |
Pfizer
PFE
|
+$1.22B |
Sector Composition
| 1 | Technology | 19.69% |
| 2 | Healthcare | 15.84% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Datadog
DDOG
$48.5B
| $45.9M | 0.01% |
+1,352,700
| New | +$45.9M |
|
|
TPTX
902
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $45.7M | 0.01% |
1,214,857
+324,807
| +36% | +$12.2M |
|
903
HarborOne Bancorp
HONE
$551M
| $45.7M | 0.01% |
4,538,142
+2,628,393
| +138% | +$26.5M |
|
904
Emergent Biosolutions
EBS
$425M
| $45.5M | 0.01% |
870,528
+57,295
| +7% | +$3M |
|
|
HCCI
905
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $45.3M | 0.01% |
1,708,666
+10,448
| +0.6% | +$277K |
|
906
Kirby Corp
KEX
$4.85B
| $45.1M | 0.01% |
549,423
-1,520
| -0.3% | -$125K |
|
|
ANSS
907
DELISTED
Ansys
ANSS
| $45M | 0.01% |
203,486
+1,856
| +0.9% | +$411K |
|
908
AtriCure
ATRC
$1.75B
| $45M | 0.01% |
1,803,174
+111,682
| +7% | +$2.79M |
|
909
Virtus Investment Partners
VRTS
$1.31B
| $44.9M | 0.01% |
405,863
-257
| -0.1% | -$28.4K |
|
|
DHR.PRA
910
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $44.6M | 0.01% |
39,210
| – | – |
|
|
CMD
911
DELISTED
Cantel Medical Corporation
CMD
| $44.5M | 0.01% |
595,435
-3,288
| -0.5% | -$246K |
|
912
Brown-Forman Class B
BF.B
$12.9B
| $44.1M | 0.01% |
702,597
+49,687
| +8% | +$3.12M |
|
|
HZNP
913
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $44M | 0.01% |
1,615,030
+513,282
| +47% | +$14M |
|
914
LyondellBasell Industries
LYB
$17.8B
| $44M | 0.01% |
491,358
-93,237
| -16% | -$8.34M |
|
915
Murphy USA
MUSA
$7.26B
| $43.9M | 0.01% |
514,885
+18,992
| +4% | +$1.62M |
|
916
Qualys
QLYS
$4.75B
| $43.4M | 0.01% |
574,937
-10,417
| -2% | -$787K |
|
917
Cactus
WHD
$2.86B
| $43.4M | 0.01% |
1,500,649
+782,679
| +109% | +$22.7M |
|
|
EVOP
918
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $43.4M | 0.01% |
1,542,199
+37,931
| +3% | +$1.07M |
|
919
American Airlines Group
AAL
$8.54B
| $43.2M | 0.01% |
1,602,506
+9,928
| +0.6% | +$268K |
|
920
Vistra
VST
$69.1B
| $43M | 0.01% |
1,609,480
-4,456,621
| -73% | -$119M |
|
921
Saic
SAIC
$4.75B
| $43M | 0.01% |
492,242
-1,502
| -0.3% | -$131K |
|
922
PENN Entertainment
PENN
$2.93B
| $42.9M | 0.01% |
2,304,205
+281,883
| +14% | +$5.25M |
|
923
Parker-Hannifin
PH
$96.9B
| $42.8M | 0.01% |
237,148
-4,666
| -2% | -$843K |
|
924
Globus Medical
GMED
$8.05B
| $42.6M | 0.01% |
833,659
+46,659
| +6% | +$2.39M |
|
925
M&T Bank
MTB
$30.9B
| $42.4M | 0.01% |
268,393
-236
| -0.1% | -$37.3K |
|